James Millis to Prospective Studies
This is a "connection" page, showing publications James Millis has written about Prospective Studies.
Connection Strength
0.224
-
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
Score: 0.063
-
Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation. 2002 Dec 27; 74(12):1735-46.
Score: 0.029
-
Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation. Cell Transplant. 2021 Jan-Dec; 30:9636897211001774.
Score: 0.026
-
Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta-cell function after total pancreatectomy with islet autotransplantation - a prospective study. Transpl Int. 2019 03; 32(3):280-290.
Score: 0.022
-
Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation. Transplantation. 1997 Feb 15; 63(3):397-403.
Score: 0.020
-
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
Score: 0.014
-
Preservation of renal function using OKT3 in liver transplant patients. Transplant Proc. 1989 Jun; 21(3):3551-2.
Score: 0.011
-
Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. Transplantation. 1989 Jan; 47(1):82-8.
Score: 0.011
-
Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg. 2007 Aug; 246(2):301-10.
Score: 0.010
-
Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation. 2004 Apr 27; 77(8):1269-75.
Score: 0.008
-
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1378-9.
Score: 0.005
-
The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation. 1990 Aug; 50(2):219-25.
Score: 0.003